Category Archives: Uncategorized

A contact lens for slowing pediatric myopia progression has received the FDA’s approval, according to manufacturer CooperVision. Source: AAO

• Posted on: Nov 20 2019
• By: Saratoga Opthalmology
• Leave a response

This phase 3 trial assessed the safety and efficacy of OTX-101, an aqueous nanomicellar formulation of cyclosporine 0.09% for dry eye disease. Source: AAO

• Posted on: Nov 19 2019
• By: Saratoga Opthalmology
• Leave a response

This paper presents characteristics associated with adherence to annual diabetic eye exams in the United States. Source: AAO

• Posted on: Nov 18 2019
• By: Saratoga Opthalmology
• Leave a response

This week, Regenxbio sues the FDA over holds on their clinical trials, a hiker finds 4 live worms her eye and rumors hint at Apple’s augmented reality ventures. Source: AAO

• Posted on: Nov 15 2019
• By: Saratoga Opthalmology
• Leave a response

This retrospective review of 2 prior toric IOL studies compared the use of intraoperative aberrometry with current-generation formulas for eyes undergoing toric IOL implantation. Source: AAO

• Posted on: Nov 14 2019
• By: Saratoga Opthalmology
• Leave a response

Sequencing and timing of cataract surgery do not affect trabeculectomy success rates at 5 years, according this retrospective study. Source: AAO

• Posted on: Nov 13 2019
• By: Saratoga Opthalmology
• Leave a response

This secondary analysis of the Protocol S trial compared the cost-effectiveness of ranibizumab versus laser for proliferative diabetic retinopathy. Source: AAO

• Posted on: Nov 12 2019
• By: Saratoga Opthalmology
• Leave a response

The authors of this study investigated donor and recipient factors associated with operative complications in patients undergoing Descemet stripping automated endothelial keratoplasty (DSAEK). Source: AAO

• Posted on: Nov 11 2019
• By: Saratoga Opthalmology
• Leave a response

This paper reports the first case of melanoma-associated retinopathy (MAR) to be managed using intravitreal fluocinolone acetonide implants. Source: AAO

• Posted on: Nov 7 2019
• By: Saratoga Opthalmology
• Leave a response

This week, a Netflix documentary details a family’s quest to obtain the pricey gene therapy Luxturna for their child, Aldeyra’s experimental allergic conjunctivitis drug continues to impress and a young engineer may have solved a blind spot problem in cars. Source: AAO

• Posted on: Nov 7 2019
• By: Saratoga Opthalmology
• Leave a response